Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to identify and manage factors related to blood pressure control that impact organ function and survival in kidney transplant recipients. Loss of the circadian (relating to a 24-hour rhythm) blood pressure pattern is common in kidney transplant recipients and is associated with poor allograft kidney function. It is still unclear if restoring the normal day-night blood pressure (BP) pattern will translate into better allograft outcome. Although studies in patients with and without chronic kidney disease indicate that restoration of the normal nocturnal (night) dipping in BP is possible by changing the timing of the BP medications to cover the overnight period (chronotherapy), this has not been tested in kidney transplant patients.


Clinical Trial Description

The challenge in kidney transplantation is to identify and manage factors that impact allograft function and survival. Loss of the circadian blood pressure pattern is common in kidney transplant recipients and is associated with poor allograft kidney function. Nevertheless, it is unclear if restoring the normal day-night BP pattern will translate into better allograft outcome. Although studies in patients with and without chronic kidney disease indicate that restoration of the normal nocturnal dipping in BP is possible by changing the timing of the BP medications to cover the overnight period (chronotherapy), this has not been tested in kidney transplant patients. This exploratory study is driven by the hypothesis that chronotherapy will restore the normal circadian BP pattern and will translate into better allograft function and into lower LVM 1-year from transplantation. ;


Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT01093703
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase N/A
Start date December 2008
Completion date November 2012

See also
  Status Clinical Trial Phase
Completed NCT03697317 - Televideo Exercise and Nutrition Program for Kidney Transplant Recipients N/A
Completed NCT06011850 - Investigation of the Effects of Quadratus Lumborum Block Applied to Patients in Kidney Transplant Surgery
Completed NCT00307125 - Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies Phase 2
Completed NCT01087190 - Isoniazid (INH) Treatment Based on ELISPOT Assay N/A
Completed NCT01753505 - Clinical Significance of 64-slice Multidetector Coronary CT Angiography to Evaluate the Prevalence and Severity of Coronary Artery Disease in Renal Transplant Recipients N/A
Recruiting NCT05975450 - Subcutaneous Abatacept in Renal Transplant Recipients Phase 1
Completed NCT00189150 - Pharmacokinetics of Mmf and Valganciclovir Phase 4
Active, not recruiting NCT05220397 - Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients Phase 3